Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

See all formats and pricing


Select Volume and Issue


30,00 € / $42.00 / £23.00

Get Access to Full Text

Mutation Detection and Mutation Databases

Richard G. H. Cotton

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 36, Issue 8, Pages 519–522, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.1998.088, June 2005

Publication History

Published Online:


Detection of mutations in genes is vital throughout biology, however, this activity is time-consuming, expensive and requires a high degree of skill. This is unsatisfactory in a field which is increasing importance. Around 10–12 methods are commonly used with some predominating. All have their advantages and disadvantages and none is perfect. Sequencing is said to be the gold standard for detecting new mutations (and must be used to define it), but six or so methods have been described to make the search quicker to avoid sequencing the whole gene. These are called scanning methods. Other methods are used to detect known mutations and referred to as diagnostic methods. These methods will be briefly reviewed. Once mutations are described, they are usually published. The mutation lists are collected for convenience, analysis or research. In recent years, it has been realised that these lists are vital for research, patient care and commercial activities. These activities will be reviewed and the co-ordinating role of the HUGO Mutation Database Initiative will be outlined.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Emmanuel Spanakis, Mohammed Al-Dahmesh, and Ian N.M. Day
Technical Tips Online, 2001, Volume 6, Number 1, Page 24
TG Hammond, A Hu, JM Hammond, MV Relling, and JL Underwood
Clinical Immunology Newsletter, 1999, Volume 19, Number 12, Page 121
Mark Harland, Alisa M. Goldstein, Kairen Kukalizch, Claire Taylor, David Hogg, Susana Puig, Celia Badenas, Nelleke Gruis, Jeanet ter Huurne, Wilma Bergman, Nicholas K. Hayward, Mitchell Stark, Hensin Tsao, Margaret A. Tucker, Maria Teresa Landi, Giovanna Bianchi Scarra, Paola Ghiorzo, Peter A. Kanetsky, David Elder, Graham J. Mann, Elizabeth A. Holland, D. Timothy Bishop, and Julia Newton Bishop
European Journal of Cancer, 2008, Volume 44, Number 9, Page 1269
Khalid K. Alharbi, Emmanuel Spanakis, Karen Tan, Matt J. Smith, Mohammed A. Aldahmesh, Sandra D. O'Dell, Avan Aihie Sayer, Debbie A. Lawlor, Shah Ebrahim, George Davey Smith, Stephen O'Rahilly, Sadaf Farooqi, Cyrus Cooper, David I.W. Phillips, and Ian N.M. Day
Human Mutation, 2007, Volume 28, Number 3, Page 294
R. R. Valiev, R. I. Khusainova, I. A. Kutuev, and E. K. Khusnutdinova
Molecular Biology, 2006, Volume 40, Number 6, Page 922
Jiří Drábek
ELECTROPHORESIS, 2001, Volume 22, Number 6, Page 1024

Comments (0)

Please log in or register to comment.